Insider Cluster (2 insiders) ·Filed Aug 11, 2026

MIRM

Mirum Pharmaceuticals, Inc.
BEARISH
Impact 5/10
Horizondays Processed1mo ago
Insider cluster: 2 insiders, $1.3M total
Actionable Insight ▼ Bearish

CEO selling following an earnings miss and pipeline delay is a cautionary signal, but the dollar amount is small relative to market cap. Monitor for additional insider sales in the next 2 weeks; if C-suite selling continues, it would reinforce the bearish read. The volixibat Phase 3 requirement and timeline — not insider trades — remain the primary catalyst for the stock.

DirectionBearish
Confidencemedium
Horizondays
Latest settled — T+20d ⚠ clustered
MIRM ▲ +1.66% at T+20d
SHORT call ✗ call lost -1.66% · α vs SPY -3.55% · entry $98.97 → $100.61
Next anchor: T+60d in 5w
Latest observation: T+33 -6.99% FF3 residual α
Entry anchored
Aug 11, 04:00 PM ET
via 1-min bar
T+1d
-0.20%
call +0.20% · α +0.90%
$98.77
settled 7w ago
T+5d
+3.30%
call -3.30% · α -3.75%
$102.24
settled 6w ago
T+20d
+1.66%
call -1.66% · α -3.55%
$100.61
settled 23d ago
T+60d
—
call — · α —
—
in 5w

Price Chart

Loading chart...

Executive Summary

CEO Christopher Peetz executed a cluster of open-market sales totaling ~$1.98M, including a single-day sale of 11,683 shares at ~$1.15M, alongside derivative exercises. The sales follow a Q2 earnings miss and volixibat pipeline delay reported 6 days prior. While the dollar amount is modest relative to Mirum's $6.4B market cap (0.03%), the CEO's status amplifies the signal — particularly given the negative earnings surprise and pipeline setback disclosed in the same window.

Key Financial Metrics

Direction
selling
Total Value
$2.0M
Insiders
2

Key Facts

  • CEO Peetz sold ~$1.98M in open-market sales on 2026-08-10, the largest being 11,683 shares at ~$1.15M
  • Total cluster value of ~$2.32M (including Jolanda Howe's $194K sale) represents ~0.04% of Mirum's $6.4B market cap
  • Sales occurred 6 days after Q2 2026 earnings (GAAP EPS -$1.06 vs -$0.75 consensus) and a volixibat NDA delay to H1 2027
  • Peetz also exercised 40,000 derivative shares (20,000 at $2.936; 20,000 at $0) — these are non-cash events
  • Prior insider activity (30d): 4 sells totaling $2.2M at higher prices, suggesting a selling pattern

Financial Impact

CEO open-market sales of ~$1.98M; cluster total ~$2.32M, 0.04% of market cap

insider ownershipdilution from derivative exercise

Risk Factors

  • Further insider sales could signal deteriorating management confidence
  • Q2 EPS miss and volixibat delay already pressured sentiment; additional negative news could compound
  • CEO derivative exercises (40,000 shares) will add to share count, though at minimal cost basis

Market Snapshot

Exchange
Nasdaq
Sector
Pharmaceutical Preparations
Analyst Consensus
95% bullish (20 analysts)

Investment Themes

Biotech & Drug Discovery

Documents Analyzed

This report is based on 1 SEC document filed with EDGAR.

DocumentAccession Number
CLUSTER Data (Synthetic)cluster-MIRM-1786485690367
16 reports for MIRM
Performance horizon
75% Hit rate 3 of 4 directional calls best @ T+20▲ +28.29%Jun 11, 2026
Filters
Rows
Reports for MIRM — sortable, filterable
TypeNow
Aug 19, 2026
6w ago
Insider Cluster
NEUTRAL ★ 3/10
$102.24 $98.82▼ −3.35%▼ −1.39%$82.93 (−18.89%)
Aug 12, 2026
7w ago
Insider Cluster
NEUTRAL ★ 3/10
$98.97 $100.61▲ +1.66%▲ +3.55%$82.93 (−16.21%)
Aug 11, 2026
7w ago
Insider Cluster
BEARISH ★ 5/10
$98.97 $100.61▼ −1.66%▼ −3.55%$82.93 (+16.21%)
Aug 10, 2026
7w ago
144
NEUTRAL ★ 3/10
$98.23 $98.30▲ +0.07%▲ +1.13%$82.93 (−15.58%)
Aug 5, 2026
8w ago
8-K
MIXED ★ 6/10
$94.12 $100.63▲ +6.92%▲ +6.32%$82.93 (−11.88%)
Jul 8, 2026
12w ago
Insider Cluster
NEUTRAL ★ 2/10
$128.57 $105.79▼ −17.72%▼ −20.99%$82.93 (−35.50%)
Jun 11, 2026
16w ago
Institutional Cluster
BULLISH ★ 6/10
$99.54 $127.70▲ +28.29%▲ +26.40%$82.93 (−16.69%)
Jun 10, 2026
16w ago
Insider Cluster
NEUTRAL ★ 3/10
$94.00 $127.70▲ +35.85%▲ +32.23%$82.93 (−11.78%)
Jun 2, 2026
17w ago
Insider Cluster
NEUTRAL ★ 2/10
$91.84 $125.59▲ +36.76%▲ +37.76%$82.93 (−9.70%)
Jun 1, 2026
17w ago
144
NEUTRAL ★ 3/10
$92.17 $120.46▲ +30.69%▲ +32.26%$82.93 (−10.02%)
Showing 10 of 16

US Market Status

Market Closed — Opens Mon (64h 41m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access
Report published Aug 11, 2026